The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

Would the Trump administration's recently proposed drug pricing reforms hurt the biotech sector more than pharma? Seeking ...

Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today ...

Maryland Gov. Wes Moore signed a bill that will allow a state board to extend its mandate for lowering prescription drug ...

Novotech is a winner in the Diversity, Research and Development, and Marketing categories in the 2025 Pharmaceutical ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's ...

BioSpace examines the busiest corporate venture capital arms in the pharmaceutical industry. Novo Holdings, which made ...

US President Donald Trump released an executive order on May 12 calling for a 30-day negotiation period between the ...

Tucked inside Trump's drug-pricing executive order is an apparent threat to withdraw drugmakers' medicines if they do not ...

The order is expected to impact innovator companies, which may spend less on research in an effort to cut costs, analysts ...

ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market.

In a world increasingly reliant on biologics and precision medicine, it’s clear that advanced cold storage is not just a ...